EDX Medical Group Plc
EDX · AIM · Health Care · mcap £38m · 8.0p
| Date | Type | Announcement | Day |
|---|---|---|---|
| 01 Oct 26 | Investor Presentation Via Investor Meet Company
CAMBRIDGE, UK: EDX Medical Group plc, which develops and supplies innovative digital diagnostic products and services to improve the early detection and treatment of major diseases, is pleased to announce that Professor |
+0.0% | |
| 17 Sep 26 | Employee health contract with Arnold Clark Group
CAMBRIDGE, UK: EDX Medical Group plc, which develops and supplies innovative digital diagnostic products and services to improve the early detection and treatment of major diseases, announces the Company has entered into |
+5.9% | |
| 03 Sep 26 | Results | Publication - Annual Report & Financial Statements
CAMBRIDGE, UK: EDX Medical Group, which develops and supplies innovative digital diagnostic products and services to improve early detection and treatment of major diseases, has today published its Annual Report and Fina |
+0.0% |
| 27 Aug 26 | Scottish Prostate Cancer Initiative update
CAMBRIDGE, UK: EDX Medical Group plc, which develops and supplies innovative digital diagnostic products and services to improve the early detection and treatment of major diseases, announces that, as the lead delivery p |
+0.0% | |
| 24 Aug 26 | Fundraise | Equity Fundraising of £2.7 million
CAMBRIDGE, UK: EDX Medical Group plc, which develops and supplies innovative digital diagnostic products and services to improve the early detection and treatment of major diseases, announces that it has raised approxima |
+15.4% |
| 03 Aug 26 | Rapid pneumonia test deployed for NHS patients
CAMBRIDGE, UK: EDX Medical Group plc, which develops innovative digital diagnostic products and services for major diseases, announces today that the Company and its partners have completed the development and technical |
−2.4% | |
| 21 Jul 26 | Full launch of bowel cancer testing service (BC95)
CAMBRIDGE, UK: EDX Medical Group plc, which develops innovative digital diagnostic products and services for major diseases, announces today the full availability of the Company's comprehensive bowel cancer biomarker te |
+2.3% | |
| 15 Jul 26 | Launch of employee health screening service
CAMBRIDGE, UK: EDX Medical Group plc, which develops innovative digital diagnostic products and services supporting personalised treatments for major diseases, announces that it is launching a new health and wellbeing sc |
+2.4% | |
| 08 Jul 26 | EDX Medical service agreement with Astron Health
EDX MEDICAL PROVIDES MOLECULAR PROFILING SERVICE TO ASTRON HEALTH |
+9.1% | |
| 26 Jun 26 | Result of General Meeting
CAMBRIDGE, UK: EDX Medical (TIDM: EDX), which develops innovative digital diagnostic products and services supporting personalised treatments for cancer and infectious diseases, today announces the results of its general |
+0.0% | |
| 04 Jun 26 | Rule 17 disclosure
CAMBRIDGE, UK: EDX Medical (TIDM: EDX), which develops innovative digital diagnostic products and services supporting personalised treatments for cancer and infectious diseases, provides the following update pursuant to |
−2.3% | |
| 04 Jun 26 | Expiration of warrants
CAMBRIDGE, UK: EDX Medical Group plc (AIM: EDX), which develops innovative digital diagnostic products and services supporting personalised treatments for cancer, heart disease and infectious diseases, announces the expi |
−2.3% | |
| 13 May 26 | First Day of Dealings on AIM
CAMBRIDGE, UK: EDX Medical (TIDM: EDX), which develops innovative digital diagnostic products and services supporting personalised treatments for cancer and infectious diseases, is pleased to announce that the admission |
||
| 21 Apr 26 | Granting of options over ordinary shares
CAMBRIDGE, UK: EDX Medical Group plc ("EDX Medical", the "Company" or the "Group"), which develops innovative digital diagnostic products and services for the personalised treatment for cancer, heart disease and infectio |
||
| 13 Apr 26 | Proposed application for admission to AIM
Proposed application for admission to trading on AIM and proposed withdrawal of Shares from AQSE |
||
| 25 Mar 26 | Scottish Prostate Cancer Initiative
CAMBRIDGE, UK: EDX Medical Group plc, which develops innovative digital diagnostic products and services supporting personalised treatments for cancer, cardiovascular and infectious diseases, announces that the Company i |
||
| 04 Mar 26 | Exercise of Warrants
CAMBRIDGE, UK: EDX Medical Group plc (AQSE: EDX), which develops innovative digital diagnostic products and services supporting personalised treatments for cancer, heart disease and infectious diseases, announces that a |
||
| 16 Feb 26 | Fundraise | Equity Fundraising raises £3.5 million
CAMBRIDGE, UK: EDX Medical Group plc, which develops innovative digital diagnostic products and services supporting personalised treatments for cancer, cardiovascular and infectious diseases, announces that the board of |
|
| 19 Dec 25 | Results | Half-year Results
Interim report: Six months to 30 September 2025 |
|
| 18 Dec 25 | Commercial launch of bowel cancer testing service
COMMERCIAL LAUNCH OF COMPREHENSIVE BOWEL CANCER TESTING SERVICE (BC95) |
||
| 20 Oct 25 | EDX Medical secures up to £4million funding
CAMBRIDGE, UK: EDX Medical Group plc, which develops innovative digital diagnostic products and services supporting personalised treatments for cancer, cardiovascular and infectious diseases, announces that the Company h |
||
| 07 Oct 25 | Advance testicular cancer testing service launched
OF HIGHLY ACCURATE TC100 TESTICULAR CANCER TESTING SERVICE |
Company filings. Not investment advice.